Cargando…
Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer
Autores principales: | Sugase, Takahito, Takahashi, Tsuyoshi, Serada, Satoshi, Fujimoto, Minoru, Ohkawara, Tomoharu, Hiramatsu, Kosuke, Koh, Masahiro, Saito, Yurina, Tanaka, Koji, Miyazaki, Yasuhiro, Makino, Tomoki, Kurokawa, Yukinori, Yamasaki, Makoto, Nakajima, Kiyokazu, Hanazaki, Kazuhiro, Mori, Masaki, Doki, Yuichiro, Naka, Tetsuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522840/ https://www.ncbi.nlm.nih.gov/pubmed/34676057 http://dx.doi.org/10.18632/oncotarget.28096 |
Ejemplares similares
-
Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer
por: Sugase, Takahito, et al.
Publicado: (2018) -
Anti-glypican-1 antibody–drug conjugate is a potential therapy against pancreatic cancer
por: Nishigaki, Takahiko, et al.
Publicado: (2020) -
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
por: Saito, Yurina, et al.
Publicado: (2019) -
Overexpression of leucine‐rich α2‐glycoprotein‐1 is a prognostic marker and enhances tumor migration in gastric cancer
por: Yamamoto, Masaaki, et al.
Publicado: (2017) -
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma
por: Hara, Hisashi, et al.
Publicado: (2016)